Does RANIBIZUMAB Cause Off label use? 1,467 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,467 reports of Off label use have been filed in association with RANIBIZUMAB (CIMERLI). This represents 9.6% of all adverse event reports for RANIBIZUMAB.
1,467
Reports of Off label use with RANIBIZUMAB
9.6%
of all RANIBIZUMAB reports
100
Deaths
96
Hospitalizations
How Dangerous Is Off label use From RANIBIZUMAB?
Of the 1,467 reports, 100 (6.8%) resulted in death, 96 (6.5%) required hospitalization, and 14 (1.0%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RANIBIZUMAB. However, 1,467 reports have been filed with the FAERS database.
What Other Side Effects Does RANIBIZUMAB Cause?
Death (2,250)
Visual acuity reduced (1,342)
Visual impairment (1,185)
No adverse event (1,012)
Drug ineffective (831)
Blindness (760)
Vision blurred (711)
Eye pain (632)
Cerebrovascular accident (543)
Endophthalmitis (542)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which RANIBIZUMAB Alternatives Have Lower Off label use Risk?
RANIBIZUMAB vs RANIMUSTINE
RANIBIZUMAB vs RANITIDINE
RANIBIZUMAB vs RANITIDINE\RANITIDINE
RANIBIZUMAB vs RANOLAZINE
RANIBIZUMAB vs RAPAMUNE